Mettler-Toledo Free Cash Flow 2010-2025 | MTD
Mettler-Toledo annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Mettler-Toledo free cash flow for the quarter ending March 31, 2025 was 177.19, a year-over-year.
- Mettler-Toledo free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.
- Mettler-Toledo annual free cash flow for 2024 was $0.866B, a 0.54% increase from 2023.
- Mettler-Toledo annual free cash flow for 2023 was $0.861B, a 16.68% increase from 2022.
- Mettler-Toledo annual free cash flow for 2022 was $0.738B, a 8.28% decline from 2021.
| Mettler-Toledo Annual Free Cash Flow | |
|---|---|
| 2024 | 866.08 |
| 2023 | 861.39 |
| 2022 | 738.23 |
| 2021 | 804.90 |
| 2020 | 635.31 |
| 2019 | 507.53 |
| 2018 | 430.47 |
| 2017 | 400.87 |
| 2016 | 337.22 |
| 2015 | 358.24 |
| 2014 | 330.25 |
| 2013 | 263.79 |
| 2012 | 232.54 |
| 2011 | 184.87 |
| 2010 | 194.69 |
| 2009 | 174.65 |
| Mettler-Toledo Quarterly Free Cash Flow | |
|---|---|
| 2025-03-31 | 177.19 |
| 2024-12-31 | 866.08 |
| 2024-09-30 | 640.27 |
| 2024-06-30 | 406.96 |
| 2024-03-31 | 172.60 |
| 2023-12-31 | 861.39 |
| 2023-09-30 | 612.13 |
| 2023-06-30 | 368.54 |
| 2023-03-31 | 130.07 |
| 2022-12-31 | 738.23 |
| 2022-09-30 | 466.45 |
| 2022-06-30 | 247.72 |
| 2022-03-31 | 71.69 |
| 2021-12-31 | 804.90 |
| 2021-09-30 | 601.32 |
| 2021-06-30 | 360.30 |
| 2021-03-31 | 134.27 |
| 2020-12-31 | 635.31 |
| 2020-09-30 | 419.45 |
| 2020-06-30 | 213.69 |
| 2020-03-31 | 46.68 |
| 2019-12-31 | 507.53 |
| 2019-09-30 | 331.36 |
| 2019-06-30 | 182.38 |
| 2019-03-31 | 76.46 |
| 2018-12-31 | 430.47 |
| 2018-09-30 | 277.58 |
| 2018-06-30 | 159.70 |
| 2018-03-31 | 51.30 |
| 2017-12-31 | 400.87 |
| 2017-09-30 | 275.85 |
| 2017-06-30 | 167.06 |
| 2017-03-31 | 56.59 |
| 2016-12-31 | 337.22 |
| 2016-09-30 | 256.44 |
| 2016-06-30 | 133.74 |
| 2016-03-31 | 27.29 |
| 2015-12-31 | 358.24 |
| 2015-09-30 | 233.35 |
| 2015-06-30 | 127.99 |
| 2015-03-31 | 40.10 |
| 2014-12-31 | 330.25 |
| 2014-09-30 | 217.26 |
| 2014-06-30 | 114.15 |
| 2014-03-31 | 26.32 |
| 2013-12-31 | 263.79 |
| 2013-09-30 | 180.62 |
| 2013-06-30 | 77.97 |
| 2013-03-31 | 4.69 |
| 2012-12-31 | 232.54 |
| 2012-09-30 | 152.03 |
| 2012-06-30 | 68.97 |
| 2012-03-31 | 2.36 |
| 2011-12-31 | 184.87 |
| 2011-09-30 | 115.56 |
| 2011-06-30 | 55.34 |
| 2011-03-31 | -10.99 |
| 2010-12-31 | 194.69 |
| 2010-09-30 | 166.86 |
| 2010-06-30 | 99.56 |
| 2010-03-31 | 34.07 |
| 2009-12-31 | 174.65 |
| 2009-09-30 | 153.81 |
| 2009-06-30 | 86.79 |
| 2009-03-31 | 24.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $23.806B | $3.872B |
| Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The company focuses on the high value-added segments of the weighing instruments market by providing solutions for specific applications. Mettler-Toledo is also a leading provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. The company has three reportable segments: Laboratory Instruments, Industrial Instruments and Retail Weighing Solutions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Edwards Lifesciences (EW) | United States | $43.397B | 28.45 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| DexCom (DXCM) | United States | $31.765B | 49.10 |
| IQVIA Holdings (IQV) | United States | $26.748B | 14.98 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| Waters (WAT) | United States | $20.195B | 28.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Hologic (HOLX) | United States | $14.255B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.848B | 0.00 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |